Bristol-Myers Sues Teva To Block Generic Baraclude
Bristol-Myers Squibb Co. has slapped Teva Pharmaceutical Industries Ltd. with a lawsuit, accusing it of infringing a patent covering the hepatitis B drug Baraclude....To view the full article, register now.
Already a subscriber? Click here to view full article